Scope
Define systems, sites, user groups, and interfaces included in the cutover so responsibilities and exclusions are clear to all stakeholders.
A documented cutover reduces clinical risk, preserves medication history integrity, and minimizes downtime for dispensing and billing systems. It provides traceability for decisions and helps satisfy internal auditors and regulators.
Teams and roles responsible for cutover execution and oversight.
The document also serves downstream as an audit artifact and a reference for post‑cutover remediation.
Define systems, sites, user groups, and interfaces included in the cutover so responsibilities and exclusions are clear to all stakeholders.
Map data elements, transformation rules, reconciliation steps, acceptable error thresholds, and validation checks for patient records and inventory.
Detail unit, integration, parallel, and user acceptance testing criteria, including test scripts, expected results, and sign‑off authorities.
Assign owners for decisions, approvals, and contingency actions; include on‑call lists and escalation paths for the go‑live window.
Specify rollback conditions, the stepwise rollback procedure, data reconciliation after rollback, and criteria for reattempting cutover.
List compliance checkpoints for HIPAA, state pharmacy boards, DEA controlled substances rules, and mandatory reporting requirements during the transition.
| Field | Configuration |
|---|---|
| Signature Type | Enable electronic signature with audit trail; require signer name and date fields. |
| Authentication | Select email link or SMS code for signer verification; use stronger KBA for sensitive signers. |
| Conditional Fields | Show or hide sections based on selections (e.g., controlled substance transfer details). |
| Retention | Enable secure archiving and export formats (PDF/A) to satisfy reproducibility requirements. |
Confirm compatibility with your pharmacy systems, security controls, and operational workflows before cutover.
Plan for testing each integration end-to-end and retain test logs for post‑cutover review.
Final approved plan signed by authorized approvers saved as PDF/A with embedded audit trail; include version history and signatory metadata for audit purposes.
CSV or database export showing source record ID, destination record ID, transformation notes, and reconciliation status for each migrated item.
Consolidated UAT results, script outputs, screenshots, and issue logs demonstrating acceptance criteria were met prior to go‑live.
Document rollback triggers, actions taken, and post‑rollback reconciliation saved with timestamps and responsible party identifiers.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7‑day free trial | Varies by promotion | Varies by promotion | Varies by promotion | Varies by promotion |
| Bulk Send | Yes (Business Premium) | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes (BAA required) | Yes | Yes | No | No |
| Envelope Cap | No envelope cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |
Allow 5–10 business days for leadership review and signature collection before freeze.
Implement a 24–72 hour data freeze immediately prior to migration to reduce reconciliation variance.
Schedule off‑hours migration window (4–12 hours) with rollbacks planned in 15‑minute checkpoints.
Perform 48–72 hours of post‑cutover monitoring and clinical validation.
Obtain documented acceptance within 7 business days after stabilization to close the project phase.
All stakeholders approve scope and schedule before data freeze.
Test scripts pass with zero critical defects and signed UAT.
Data moved to production with live reconciliation and monitoring enabled.
KPIs meet acceptance thresholds and final sign‑off recorded.